INDIANAPOLIS—Lilly Endowment Inc., a major shareholder in Eli Lilly & Co. (NYSE:LLY), has recently sold a significant portion ...
Most patients with moderately to severely active Crohn’s disease who achieved endoscopic response and remission after 52 ...